4//SEC Filing
SOLAZYME INC 4
Accession 0001555667-14-000079
CIK 0001311230operating
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 6:23 PM ET
Size
7.2 KB
Accession
0001555667-14-000079
Insider Transaction Report
Form 4
SOLAZYME INCSZYM
Wolfson Jonathan S
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2014-09-09$8.52/sh−64,375$548,494→ 2,261,725 total(indirect: By Trust)
Holdings
- 8,751(indirect: By Trust)
Common Stock
- 282,500
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were almost exclusively to cover tax withholding obligations in connection with the vesting of restricted stock units immediately prior to the date of sale.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.67, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Excludes 8,751 shares previously owned by the Jonathan S. Wolfson Revocable Trust dated August 12, 2010 that were contributed to the Wolfson Revocable Trust dated August 12, 2010.
- [F4]The Jonathan S. Wolfson Revocable Trust dated August 12, 2010.
- [F5]The Wolfson Revocable Trust dated August 12, 2010.
Documents
Issuer
SOLAZYME INC
CIK 0001311230
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311230
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 6:23 PM ET
- Size
- 7.2 KB